Rich Nelson

In addition to his role as Executive Vice President of Corporate Development for vTv Therapeutics, Rich Nelson is also Executive Vice President of Corporate Development for MacAndrews & Forbes (“M&F”) and Vericast, where Rich is responsible for the identification and execution of global merger and acquisition opportunities. In this role, Rich works with business leaders to source, negotiate and close acquisitions, joint ventures, and partnerships that complement M&F’s and Vericast’s long-term vision and strategy. Rich brings more than 25 years of experience in mergers and acquisitions. Prior to Vericast, Rich served as Senior Vice President of Global Corporate Development at The Nielsen Company. Rich also served as Managing Director, Mergers and Acquisitions at IAC/InterActive Corp. Previously, Rich had been President and Co-Founder of Trendum, n/k/a Nielsen BuzzMetrics, and SVP/General Counsel of RSL Communications, a telecommunications company. Rich began his career as a mergers and acquisition attorney at Skadden Arps. Rich earned his Bachelor of Business Administration in Finance with High Distinction from the Ross School of Business at the University of Michigan and a J.D. from the New York University School of Law. Rich is a member of the National Advisory Board for the University of Michigan Rogel Cancer Center, the Board of Directors of Think Pink Rocks breast cancer charity, and a former member of the Board of Directors of Reply.com, RSL COM U.S.A. and Trendum, Inc. Rich is an active venture investor and advisor to various stage private companies and their Boards, including Woolsey Pharmaceuticals.